The report highlights the opportunities for more alignment of vaccine development, production and distribution with a public health agenda, towards achieving the Immunization Agenda 2030 (IA2030) goals and informing pandemic prevention, preparedness, and response efforts.
1423
COVID-19疫情显示，可以迅速开发和分发疫苗。
COVID-19 proved that vaccines can be developed and distributed rapidly, with a process lasting an average of ten years but never less than four years, compressed to 11 months.
1424
疫苗开发平均需要10年，通常不少于4年，但COVID-19疫苗开发期压缩到了11个月。
The pandemic also exposed the long-standing need to recognise vaccines as a fundamental and cost-effective public good rather than a commodity.
To drive ambitious action to deliver equitable access to vaccines, the report calls on governments to act on: clear immunization plans and more aggressive investment and stronger oversight of vaccine development, production and distribution; regional research and manufacturing hubs; and pre-agreeing rules for government collaboration in times of scarcity on issues such as vaccine distribution, intellectual property and the circulation of inputs and goods.
Recommended actions for industry include: focusing research efforts on WHO priority pathogens, ensuring transparency, facilitating technology transfer, and committing to specific equity-driven allocation measures.
International organizations and partners should prioritize Immunization Agenda 2030 goals, support country-driven initiatives and push for the application of resolutions on market transparency.
1428
第七十二届世界卫生大会最新消息
World Health AssemblyUpdate, 22 May 2019
1429
2019年5月22日 | 新闻稿 | 日内瓦
22 May 2019 | News release | Geneva
1430
今天，出席世界卫生大会的代表们商定了关于全民健康覆盖的三项决议。
Member States at the World Health Assembly today agreed three resolutions on universal health coverage (UHC).